Allied Biotech (ROCO:1780) Change In Inventory: NT$11.7 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1780 Allied Biotech Corp ROCO:1780
81 GF Score
Price NT$24.80
GF Value NT$22.13
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Allied Biotech Change In Inventory?

Allied Biotech ROCO:1780 81 Change In Inventory is NT$11.7 Mil as of Jun. 2026. GuruFocus rates ROCO:1780 with a GF Score™ of 81/100 and a GF Value™ of NT$22.13 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Allied Biotech's change in inventory for the quarter that ended in Jun. 2026 was NT$24.7 Mil. It means Allied Biotech's inventory declined by NT$24.7 Mil from Mar. 2026 to Jun. 2026 .

Allied Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was NT$16.1 Mil. It means Allied Biotech's inventory declined by NT$16.1 Mil from Dec. 2024 to Dec. 2025 .

Allied Biotech's Total Inventories for the quarter that ended in Jun. 2026 was NT$483.3 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Allied Biotech's Days Inventory for the quarter that ended in Jun. 2026 was 309.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. Allied Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Allied Biotech's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.92.

Allied Biotech  (ROCO:1780) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Allied Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=495.627/146.297*365 / 4
=309.14

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Allied Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=146.297 / 495.627
=0.30

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Allied Biotech's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=495.627 / 258.146
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech Change In Inventory Related Terms

Allied Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Allied Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Biotech Change In Inventory Chart

Allied Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.84 -88.39 -5.00 73.94 16.13

Allied Biotech Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.26 -11.14 -5.31 3.42 24.71
ROCO:1780
81GF Score
Allied Biotech Corp ROCO:1780
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allied Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$11.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$11.7 Mil mean?
Allied Biotech (ROCO:1780) has a Change In Inventory of NT$11.7 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Allied Biotech and its competitors.
Is Allied Biotech's Change In Inventory too high?
Allied Biotech's current Change In Inventory is NT$11.7 Mil. Overall, Allied Biotech has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Change In Inventory compare to ZTS?
Allied Biotech's Change In Inventory of NT$11.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Allied Biotech and its competitors. Allied Biotech's current Change In Inventory is NT$11.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$22.13, compared to a current price of NT$24.80 — trading 12.1% above its estimated fair value. The current Change In Inventory is NT$11.7 Mil. Allied Biotech's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Change In Inventory is NT$11.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allied Biotech (ROCO:1780) Overvalued in 2026?

Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued. The current stock price of NT$24.80 is trading 12.1% above its estimated GF Value™ of NT$22.13. GuruFocus considers Allied Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:1780:

  • Change In Inventory: NT$11.7 Mil
  • GF Value™: NT$22.13 vs. price of NT$24.80 (12.1% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allied Biotech Business Description

Address No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
81GF Score

Get the complete analysis for ROCO:1780

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.80
Price
NT$22.13
GF Value